A single-arm, multi-center phase II study of tislelizumab combined with lenvatinib and GEMOX as conversion therapy in potentially resectable locally advanced biliary tract cancer (ZSAB-TransGOLP): A primary analysis.
| Autor: | Fan, Jia, Zhou, Jian, Shi, Guoming, Huang, Xiaoyong, Gao, Qiang, Li, Xiaowu, Ji, Yuan, Liang, Fei, Chen, Yi, Lu, Pinxiang, Qiu, Shuangjian, Ren, Ning, Shen, Yinghao, Xu, Yongfeng, Ding, Zhenbin, Zhu, Xiaodong, Sun, Huichuan, Shi, Yinghong, Wang, Xiaoying, Yi, Yong |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p488-488, 151p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|